Last reviewed · How we verify
Calcium Levofolinate Hydrateb — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcium Levofolinate Hydrateb (Calcium Levofolinate Hydrateb) — Ono Pharmaceutical Co. Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcium Levofolinate Hydrateb TARGET | Calcium Levofolinate Hydrateb | Ono Pharmaceutical Co. Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcium Levofolinate Hydrateb CI watch — RSS
- Calcium Levofolinate Hydrateb CI watch — Atom
- Calcium Levofolinate Hydrateb CI watch — JSON
- Calcium Levofolinate Hydrateb alone — RSS
Cite this brief
Drug Landscape (2026). Calcium Levofolinate Hydrateb — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-levofolinate-hydrateb. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing